Prenetics Global Ltd
PRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001876431
In the last 90 days, Prenetics Global Ltd insiders filed 2 open-market purchases and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $23.3M in total; no superinvestor holds it.
Other share classesPRENW
Q3 2023 vs. Q2 2023
How the institutions holding Prenetics Global Ltd changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 20 | 15 | −5 |
| Shares | 16.6M | 15.9M | −626.5K (−3.8%) |
| Value | $14.7M | $7.69M | −$7.06M (−47.9%) |
New holders (1)
Institutions that held Prenetics Global Ltd at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| XTX Topco Ltd | 34,786 | $16.7K | 0.00% |
Sold out (6)
Institutions that held Prenetics Global Ltd at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Dymon Asia Capital (Singapore) Pte. Ltd. | 150,687 | $134.1K |
| Dantai Capital Ltd | 104,437 | $92.9K |
| Gladius Capital Management LP | 29,594 | $26.3K |
| HCR Wealth Advisors | 20,000 | $17.8K |
| Susquehanna International Group, LLP | 17,382 | $15.5K |
| UBS Group AG | 408 | $363 |